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ABSTRACT 
Reduction of delay between onset and hospital arrival and adequate pre-hospital 
care of persons with acute stroke are important for improving chances of a 
favorable outcome. The objective is to recommend evidence-based practices for 
the management of patients with suspected stroke in the pre-hospital setting.  
The GRADE (Grading of Recommendations Assessment, Development and 
Evaluation) methodology was used to define the key clinical questions. An expert 
panel then reviewed the literature, established the quality of the evidence, and 
made recommendations. 
Despite very low quality of evidence we strongly recommend educational 
campaigns to increase awareness of immediately calling emergency medical 
services. We found moderate quality evidence to support strong recommendations 
for the training of emergency medical personnel in recognizing the symptoms of a 
stroke, and implementation of a pre-hospital ‘code stroke’ including highest 
priority dispatch, pre-hospital notification, and rapid transfer to the closest ‘stroke-
ready’ center. We found insufficient evidence to recommend a pre-hospital stroke 
scale to predict large vessel occlusion. Despite very low quality of evidence we 
recommend restoring normoxia in patients with hypoxia, and refrain from blood 
pressure lowering drugs and treating hyperglycemia with insulin. There is 
insufficient evidence to recommend the routine use of mobile stroke units 
delivering intravenous thrombolysis at the scene. Because only feasibility studies 
have been reported, no recommendations can be provided for pre-hospital 
telemedicine during ambulance transport.  
These guidelines inform on the contemporary approach to patients with suspected 
stroke in the pre-hospital settings. Further studies, preferably randomized 
controlled trials, are required to examine the impact of particular interventions on 
quality parameters and outcome. 
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Introduction 
Stroke is a leading cause of disability in adults and a major cause of death and 
disability. Specific therapies for acute stroke are most effective when initiated the 
sooner after symptom onset. This requires rapid clinical assessment and brain 
imaging. 
Intravenous thrombolysis with recombinant tissue plasminogen activator is 
effective in acute ischemic stroke up to 4.5 hours of symptom onset, and recent 
trials have shown significant additional benefits of thrombectomy in patients with 
large vessel occlusion [1, 2]. As time is critical for improving outcome, appropriate 
pre-hospital assessment and management of persons suspected with acute stroke 
are important for reducing delays for revascularization therapies, and in the 
meantime limiting secondary brain damage during transport. 
The purpose of this clinical guideline is to develop recommendations for the 
management of persons with suspected acute stroke from the scene to the 
hospital.  
Methodology 
A working group consisting of experts in acute stroke medicine and neurology, an 
expert on guideline methodology, and a representative of the European patient 
organization Stroke Alliance for Europe was proposed by the Stroke Scientist Panel 
of the former European Federation of Neurological Sciences (EFNS), the European 
Stroke Organisation (ESO) Guidelines Committee, and the Subcommittee for 
Cerebrovascular Diseases of the former European Neurological Society (ENS). 
The Guideline was developed in concordance with the Grading of 
Recommendations Assessment, Development and Evaluation (GRADE) 
methodology [3]. The work of this task force was set up during a stage when the 
recent standard operating procedures for writing Guideline Documents of the ESO 
and European Academy of Neurology (EAN) were not yet effective [4, 5]. 
During a first meeting, the members of the working group established a consensus 
on 14 specific PICO (patient, intervention, comparator, outcome) questions. For 
each PICO question two members were assigned to perform a literature search 
using relevant MeSH terms. A search of MEDLINE, EMBASE and the Cochrane 
Library was performed up to March 2016. Language restrictions were not applied. 
Conference reports and case reports were excluded.  
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All selected articles were cross-referenced to make certain that no relevant studies 
were excluded. References cited in the selected articles were checked for further 
relevant articles not identified by the electronic searches. Two reviewers read all 
identified papers and disagreements were resolved through discussion. When a 
recent systematic review was available to answer a PICO question, only the 
literature after publication of the systematic review was further assessed. During a 
second meeting of the working group, the quality of evidence was derived, and 
strength of recommendation was decided by consensus. Quality of evidence was 
graded as high, moderate, low or very low [3]. A summary of findings table to 
obtain an overall effect estimate is only presented when homogenous RCTs were 
available. For a number of PICO question, we add an “additional information” box 
just after the recommendation box. 
Results 
 
The recommendations for each PICO question are summarized in table 1. 
 
Rapid recognition of stroke  
PICO 1. In people with suspected acute stroke, do educational 
interventions aimed at the general public increase the likelihood of 
immediately calling emergency medical services (EMS)? 
We did not find RCTs investigating the effect of educational interventions on the 
interval between onset of symptoms and EMS call. A related but indirect outcome, 
reduction in pre-hospital delay, was recently assessed in a systematic review [6], 
including 13 studies. Only one, the Berlin Acute Stroke Study, was a cluster RCT 
[7]. The educational intervention consisted of a letter indicating stroke symptoms 
and emphasizing the need to call EMS immediately, accompanied by a sticker with 
main stroke symptoms and the telephone number of the EMS. A total of 75,720 
households received the intervention. The intervention was found to be effective in 
reducing pre-hospital delays in women but not in men. However, the study had 
several limitations, including a limited precision of time assessments. The other 
studies were before and after studies, or observational studies. Ten studies 
reported a statistically significant reduction in pre-hospital delay following the 
educational intervention. Heterogeneity and methodological weaknesses limit a 
proper meta-analysis and generalizability of the observed effects. The working 
group decided to give a strong recommendation despite the very low quality of 
evidence, because the possible benefit of early recognizing stroke symptoms by 
the general population and of immediate EMS call clearly outweighs any possible 
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harm.  Sustained campaigns should remain the cornerstone to educate the general 
population in recognizing stroke symptoms and the need to call EMS immediately. 
Recommendation 
We recommend educational campaigns to increase the awareness of immediately 
calling EMS for people with suspected stroke.  
(strong; very low quality of evidence) 
 
PICO 2. For EMS technicians and paramedics, are simple pre-hospital 
stroke scales useful to identify potential stroke patients? 
 
We identified a recent systematic review, examining the accuracy of recognizing 
pre-hospital stroke patients using the QUADAS-2 tool. The following simple stroke 
scales were included: the Face Arm Speech Test (FAST), Cincinnati Pre-Hospital 
Stroke Scale (CPSS), Los Angeles Pre-Hospital Stroke Screen (LAPSS), Melbourne 
Ambulance Stroke Screen (MASS), Medic Prehospital Assessment for Code Stroke 
(Med PACS), Ontario Prehospital Stroke Screening Tool (OPSS), and Recognition of 
Stroke in the Emergency Room (ROSIER) [6]. All of the above were observational 
studies and excluded studies in which physicians were involved in pre-hospital 
application of the stroke scale. Pre-hospital stroke scales varied in their accuracy 
and globally missed up to 30% of acute strokes in the field. All stroke scales had a 
high sensitivity, ranging from 74 to 97%. Specificity of the comparable FAST 
(13%) and CPSS (24-79%) was lower than scales including more items, such 
LAPSS (85-97%), MASS (74-86%), and OPPS (86%), with exception of Med PACS 
(33%) and ROSIER (18 %). Despite the low quality of evidence we issued a strong 
recommendation because the possible benefit of identifying potential stroke 
victims clearly outweighs any possible harm and the associated resource use is 
minimal. 
 
Recommendation 
We recommend that all EMS technicians and paramedics are familiar with a simple 
pre-hospital stroke scale to identify potential stroke patients. No specific scale can 
be recommended. 
(strong; low quality of evidence)  
 
Additional information 
Current simple pre-hospital stroke scales are not sensitive for detecting posterior 
circulation stroke. 
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PICO 3. For EMS technicians and paramedics, are pre-hospital stroke 
scales useful for predicting large vessel occlusion? 
 
A retrospective analysis of 2 databases including 119 patients reported that a 
hospital score ≥ 4 on the Los Angeles Motor Scale predicted presence of large 
artery anterior circulation occlusion with high sensitivity (81%) and specificity 
(89%) [7]. However this has not been prospectively validated. The Rapid Arterial 
oCclusion Evaluation (RACE) scale was validated prospectively in the pre-hospital 
setting by trained EMS technicians in 357 consecutive patients in a single 
comprehensive stroke center study. Large vessel occlusion was diagnosed by 
transcranial duplex, CT angiography, or MR angiography. A RACE scale score ≥5 
had a sensitivity of 85%, specificity of 68%, positive predictive value of 42%, and 
negative predictive value of 94% for detecting large artery anterior circulation 
occlusion [8]. There is insufficient evidence that these stroke scales could be 
useful instruments for selecting stroke patients for direct transport to 
comprehensive stroke centers. 
Recommendation 
There is insufficient evidence to recommend a pre-hospital stroke scale to predict 
large vessel occlusion. 
 
Rapid stabilization of vital parameters 
 
PICO 4.  In people with suspected acute stroke who are hypoxic, does 
pre-hospital O2 administration compared to no O2 administration improve 
outcome? 
Studies investigating in-hospital routine O2 therapy started < 24 hours after stroke 
onset (2 or 3 L/min for 24 - 72 h), although showing slight improvement in 
neurological status 7 days after stroke onset, failed to show a benefit in terms of 
long-term survival and independence [9-11]. No RCT has compared O2 
administration versus no O2 administration in persons suspected with acute stroke 
in the pre-hospital setting. Hypoxia should be avoided because it may amplify 
ischemic brain damage and worsen outcome [12]. Although there are no 
supportive RCTs, the working group decided to follow the guidelines published by 
the British Thoracic Society (BTS) advocating titrated oxygen therapy [13]. 
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Recommendation 
In patients with SaO2 levels < 95% we suggest the administration of O2 titrated to 
maintain normoxia. Routine use of O2 is not recommended. 
(weak; very low quality of evidence) 
 
 
PICO 5.  In people with suspected acute stroke, does pre-hospital high 
blood pressure reduction compared to no intervention on blood pressure 
improve outcome?  
Both hypertension and marked hypotension are associated with poor outcome 
after stroke [14], and there is considerable clinical uncertainty as to the optimal 
management of blood pressure acutely after stroke. There are 2 small single 
center feasibility RCTs in pre-hospital acute stroke patients who were hypertensive 
(systolic blood pressure ≥140 mm Hg or >160 mmHg) assessing safety and 
outcome of antihypertensive therapy. The Rapid Intervention With Glyceryl 
Trinitrate in Hypertensive Stroke Trial and the Paramedic Initiated Lisinopril for 
Acute stroke Treatment Trial showed that it was feasible of performing an 
ambulance-based paramedic-delivered trial of BP lowering in patients with acute 
stroke (< 4 hours of stroke onset) [15, 16]. Both of the trials selected immediate 
blood pressure lowering effect as primary outcome. Due to the small size of the 
studies (55 patients recruited in total) no conclusions on safety, efficacy and 
outcome could be drawn from this study. Even for systolic blood pressures ≥ 185 
mm Hg, which may prolong door to needle time, urgent pre-hospital 
antihypertensive treatment by paramedics holds a risk for sudden drops of the 
blood pressure, therefore treatment of high blood pressure in the pre-hospital 
phase should be avoided.  
Recommendation 
We do not recommend pre-hospital treatment of high blood pressure in people 
suspected with acute stroke. 
(weak; very low quality of evidence) 
 
PICO 6.  In people with suspected acute stroke, does pre-hospital 
treatment of hyperglycemia with insulin compared to no treatment 
improve outcome? 
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Blood glucose should be measured in every patient with suspected stroke because 
symptoms of hypoglycemia can mimic those of a stroke.  Hypoglycemia (< 60 
mg/dl or < 3.3 mmol/l) needs to be treated with glucose 20%-40% in 25-50 ml 
infusion [17]. 
 
People with hyperglycemia concomitant with large vessel acute ischemic stroke 
have greater mortality, stroke severity, and functional impairment when 
compared with those with normoglycemia. However, this has not been found in 
patients with a lacunar stroke [18, 19]. We identified only one small feasibility 
study dealing with lowering glucose in acute stroke patients in the pre-hospital 
setting [20]. In this study, patients with stroke symptoms and plasma glucose > 
108 mg/dl or 6.0 mmol/l were randomized during the pre-hospital phase to 
receive either a single subcutaneous dose of short-acting insulin (n = 11) or a 
continuous intravenous insulin infusion (n = 12) at a rate adjusted by glucose 
levels measured every 10 minutes and targeted to plasma glucose 4.5-6.0 
mmol/l. Plasma glucose levels were significantly decreased with no serious 
adverse events in the intravenously treated group in comparison to a 
nonrandomized control group (n = 38). The subcutaneous insulin administration 
did not achieve significant lowering of plasma glucose. 
 
A systematic review showed that the in-hospital administration of intravenous 
insulin with the objective of maintaining serum glucose within a specific range in 
the first hours of acute ischemic stroke does not provide benefit in terms of 
functional outcome, death, or improvement in final neurological deficit, and 
significantly increased the number of hypoglycemic episodes [21]. Specifically, 
those people whose glucose levels were maintained within a tighter range with 
intravenous insulin experienced a greater risk of symptomatic and asymptomatic 
hypoglycemia than those people in the control group. The situation may, 
therefore, be even more risky in the pre-hospital phase.  
 
Recommendation 
 
Because of safety concerns we do not recommend pre-hospital administration of 
insulin in persons with suspected stroke and hyperglycemia.  
(weak; very low quality of evidence) 
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PICO 7.  In people with suspected acute stroke, does pre-hospital 
lowering of elevated body temperature compared to no intervention on 
body temperature improve outcome? 
Data of 5305 patients from the Virtual International Stroke Trials Archive data set 
showed that delayed hyperthermia was more strongly associated with poor 
outcome than elevated body temperature seen in the hours after stroke [22]. A 
prospective study in 725 patients also found that initial elevated body temperature 
in hyperacute ischemic stroke was not associated with worse outcome, but a rise 
in body temperature in severe strokes was related to poor outcome. It was 
concluded that elevated body temperature within 6 hours of stroke onset had no 
prognostic influence on stroke outcome at 3 months [23].  
Antipyretic drugs and cooling methods can lower body temperature in stroke 
patients. However, no clinical studies have investigated pre-hospital treatment of 
elevated body temperature in acute stroke patients.  
Recommendation 
In the absence of clinical studies no recommendations can be made on pre-
hospital interventions for lowering elevated body temperature  
Rapid care by a dedicated stroke-team 
PICO 8.  In patients with suspected acute stroke, does implementation of 
pre-hospital ‘code stroke’ protocols compared to no implementation of 
such protocols reduce onset to admission time, door to needle time, and 
frequency of thrombolysis?  
The search revealed 43 citations, of which 9 studies, including 1 RCT, were 
considered relevant. The RCT, performed in the Stockholm area, compared the 
effect of upgrading the priority level at the Emergency Medical Communication 
Center (EMCC) from the standard level 2 (ambulance arrival at scene within 30 
minutes unless no priority 1 alarms required that ambulance) to level 1 
(immediate ambulance response) [24]. In the group randomized to level 1 there 
was a significant shorter delay (13 minutes) from EMCC call to arrival at the 
hospital (P<0.001) and a significant increase in thrombolysis frequency (24% 
versus 10%; P<0.001). The door to needle time was not significantly different as 
eligible patients from the control group were also prioritized at the emergency 
department. 
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Several observational studies have reported that pre-hospital notification of the 
receiving hospital without or with prioritized transport to designated hospitals with 
stroke expertise (bypassing the nearest hospitals) led to significantly shorter door 
to needle time or door to brain imaging time [25-32] and higher rates of 
intravenous thrombolysis [25, 26, 28-31]. Most studies compared findings either 
with findings from a historical control group (6) or with findings from a parallel 
observation of patients for whom no pre-notification intervention was used (2). In 
most studies improved pre-hospital management was also associated with 
improved in-hospital reorganization, indicating that pre-hospital ‘code stroke’ and 
in-hospital ‘code stroke’ are a continuum aimed at shortening onset to treatment 
time. A meta-analysis of these observational studies is not feasible because of 
different study designs and methodological approaches, and qualitative differences 
in regional EMS organization where the studies were performed. However, all 
studies consistently show that implementing a pre-hospital ‘code stroke’ protocol 
including priority EMS dispatch, rapid transport to the closest ‘stroke ready’ center 
(bypassing nearest hospitals that are not ‘stroke ready’), and pre-arrival 
notification to the receiving hospital, leads to faster times to treatment and higher 
treatment rates. 
 
Recommendation 
We recommend that all EMS implement a ‘code stroke’ protocol, including highest 
priority dispatch, pre-hospital notification, and rapid transfer to the closest ‘stroke-
ready’ center. 
(strong; moderate quality of evidence) 
 
PICO 9.  In people with suspected stroke does pre-hospital telemedicine, 
compared to no telemedicine, improve outcome?  
Telemedicine with real-time bidirectional audio-video communication between the 
ambulance and a stroke physician may enable early assessment of a patient with 
suspected stroke and might thereby reduce in-hospital delays to receive relevant 
treatment. 36 papers were identified. Pilot studies indicate that this approach is 
feasible [33, 34]. We did not find RCTs on whether pre-hospital telemedicine in 
acute stroke patients speeds up door to treatment time and improves outcome. 
Only one observational study compared door to imaging time in patients that 
received pre-hospital telemedicine (n=16) versus controls (n=42). No statistically 
significant difference was found between door to imaging time in patients that 
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received pre-hospital telemedicine: median [IQR] – 59.5 [67.5] minutes versus 
controls 57.5 [80] minutes, p=0.65 [33].  
Recommendation 
No recommendation on the additional value of pre-hospital telemedicine can be 
made.  
 
PICO 10. In patients with acute stroke, does the use of mobile emergency 
stroke units, compared to no use of such means, improve outcome?   
Studies with mobile emergency stroke units, which are specialized ambulances 
staffed by a neurologist/physician or nurse, paramedic/emergency medical 
technician, and radiology technician, and equipped with a CT scanner, point-of-
care laboratory, and telemedicine connection. Thrombolysis was administered at 
the scene. The search revealed 3 relevant studies: 2 RCTs [35, 36], and 1 small 
observational study [37]. Studies were unblinded and specific to the local setting  
Grading of the quality of evidence was based on the 2 RCTs comparing mobile 
emergency stroke unit intervention with hospital intervention (GRADE table in 
appendix). In the mobile emergency stroke unit group, rate of thrombolysis was 
increased  (OR 1.79; 95% CI: 1.44 to 2.33), with a median reduction in call to 
needle time of 24 to 34 minutes and a median reduction in onset to needle time of 
24 to 81 minutes. No safety concerns have been raised. There was no increase in 
symptomatic intracranial hemorrhage (OR 0.59; 95%CI: 0.25 to 1.38) in the 
mobile emergency stroke unit group. However, there were insufficient data about 
functional outcome to determine effectiveness. Only one study investigated 7 day 
outcome [35]. There was no significant difference between the mobile emergency 
stroke unit group and control group in the number of patients who were 
independent defined as a mRs score < 3 . In the large PHANTOM-S trial [36], 
mean door to needle time in the control group receiving usual hospital care was 
42 minutes, which could be further improved by reducing in-hospital delays. Two 
studies provided arguments in support of cost-effectiveness of mobile emergency 
stroke units [38, 39].  
Recommendation 
We do not recommend the routine use of mobile emergency stroke units because 
there is insufficient evidence that they lead to better functional outcome.  
(weak; low quality of evidence) 
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Additional comments 
Although the influence of mobile emergency stroke units on outcome of patients 
with stroke is uncertain, they can reduce onset to needle times for intravenous 
thrombolysis in patients with ischemic stroke, and can be an option for certain 
regions where traditional ambulance transport would result in significant delays.  
PICO 11. In persons with suspected acute stroke, does the use of pre-
hospital point-of-care (POC) laboratory analysis of blood count and 
International Normalized Ratio (INR), compared to no use of such means, 
speed up door to needle time in ischemic stroke or interventions to 
prevent worsening of hemorrhagic stroke?    
Determination of the platelet count and INR is important in patients taking vitamin 
K antagonists, with liver dysfunction, hemorrhagic diathesis, or with an unclear 
medication history. Observational studies reported that measuring these 
parameters by POC testing in the Emergency Department, instead of awaiting 
central laboratory results, reduced door to needle time [40, 41]. No clinical trial 
has assessed whether pre-hospital POC analyses of INR and blood count have an 
additional effect in reducing door to needle time or improving management of 
hemorrhagic stroke. 
 
Recommendation 
No recommendation on the use of pre-hospital POC laboratory analysis of blood 
count and INR can be made.  
 
PICO 12. In persons with suspected acute stroke, can biomarkers 
accurately differentiate between ischemic stroke, hemorrhagic stroke, or 
a stroke mimic?  
A comprehensive systematic review using QUADAS criteria for assessing the 
quality of studies found that no individual biomarker has adequate sensitivity and 
specificity for a clinical useful diagnostic test [42]. A number of studies have 
attempted a multi-marker panel approach in order to improve sensitivity and 
specificity. However, thus far none has been successful in a clinical setting. None 
of these studies were performed in a pre-hospital setting [42]. 
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Recommendation 
No recommendation can be made on the use of currently available biomarkers in 
persons with a suspected stroke.  
 
PICO 13. In persons suspected with acute stroke, does air medical 
transport compared to ground transport improve outcome? 
The search revealed 88 citations, of which only 1 observational study made an 
acceptable comparison to ground transport. This retrospective examination of the 
Austrian Stroke Unit Registry found that air transport was associated with greater 
thrombolysis activity compared to standard ambulance (OR 3.36; 95%CI 2.8-4.0) 
and physician ambulance (OR 1.45; 95%CI 1.2-1.7), and a mean 30 (95%CI 41 
to 18) minutes less onset to hospital arrival time compared to standard 
ambulance, but not physician ambulance (5 minutes longer; 95%CI 1 to 9) [43]. 
However there was no information regarding air transport availability or the 
criteria used to trigger its dispatch in preference to ground transport when it was 
available.  
 
Recommendation 
We do not suggest air medical transport outside of settings where a pragmatic 
decision has been taken that geographical conditions favor air transport. 
(weak; very low quality of evidence). 
PICO 14. In acute stroke patients do pre-hospital neuroprotective 
therapies improve outcome? 
We identified 3 RCTs of neuroprotective therapies initiated before hospital 
admission. 
The first study was a randomized, controlled, double blind, placebo controlled 
study of oral nimodipine 30mg every 6 hours for 10 days in patients in whom 
treatment could be initiated within 6 hours of stroke onset [44]. There was no 
significant difference between the nimodipine group and the placebo group on the 
primary outcome, which was defined as death or dependency at 3 months.  
The second study was a randomized, placebo controlled double blind study of 
intravenous infusion of magnesium sulphate started in the ambulance in both 
ischemic and hemorrhagic stroke [45]. The study included all stroke patients in 
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whom treatment could be initiated up to 2 hours after symptom onset. Active 
treatment did not decrease the risk of being dead or dependent 90 days after the 
stroke.  
The third study was a placebo-controlled, open label study of remote ischemic 
preconditioning for ischemic stroke [46]. The primary endpoint was penumbral 
salvage, defined as the volume of the perfusion–diffusion mismatch not 
progressing to infarction after 1 month. The trial failed to show a difference 
between patients receiving remote ischemic preconditioning and not. 
Recommendation 
We do not recommend the use of any neuroprotective intervention in persons with 
suspected acute stroke in the pre-hospital setting.  
(strong; high quality of evidence). 
 
Discussion 
A serious limitation of this guideline is the paucity of RCTs available on pre-
hospital management of stroke. The GRADE system only allows grading of the 
strength of recommendation as strong or weak. This on one hand allows a clear 
statement on a specific PICO question, but on the other hand does not allow an 
intermediate recommendation in cases assumed to have insufficient data. For a 
number of PICO questions no recommendation could be given because of 
insufficient data. Based on consensus we did give a strong recommendation for 
some PICO questions for which no RCTs were available, for example when 
observational studies consistently showed a similar effect, or if the panel found 
that desirable consequences outweigh undesirable consequences, or if most or all 
patients would be best served by a particular management strategy. 
Despite low quality of evidence we strongly support public educational campaigns 
to increase public awareness of immediately calling EMS for persons with 
suspected acute stroke. Studies were very heterogeneous, and the potential 
clinical benefit of public campaigns may be difficult to identify in a short-term 
follow-up. Further studies are required to find out which methods are most 
effective in successfully educating the general public about the urgency of stroke. 
We found moderate quality of evidence to strongly support the training of EMS 
personnel in recognizing the symptoms of stroke using simple stroke scales, such 
as the FAST or LAPSS. No recommendation can be given for a specific stroke 
scale.  
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We found moderate quality of evidence to strongly support implementing a pre-
hospital ‘code stroke’ system by the EMS, which includes highest priority 
ambulance dispatch, prioritized transport to the closest ‘stroke-ready’ center, and 
pre-notification of the receiving hospital. When possible, EMS should bypass 
hospitals that are not ready to immediately deliver appropriate acute stroke 
treatment. Pre-notification allows the stroke team to get ready before the patient 
actually arrives at the hospital.  
 
Further studies are required to investigate whether pre-hospital stroke scales 
predicting large vessel occlusion might be used as a triaging tool to select stroke 
patients for direct transport to comprehensive stroke centers capable of 
endovascular interventions. 
 
Very low quality of evidence is available for pre-hospital management of 
physiological parameters, such as treatment of hypoxia, management of blood 
pressure and hyperthermia. Nevertheless, we strongly recommend maintaining 
normoxia, and do not recommend the use of blood pressure lowering medication 
and the use of insulin in persons with suspected stroke and hyperglycemia, unless 
in cases of extreme urgency. 
Preliminary studies using bi-directional audiovisual telemedicine during ambulance 
transport show that this method is feasible and may provide valuable information 
to the hospital stroke team. However, such intervention should not cause any 
delay in the pre-hospital stroke care pathways, and its additional value on top of 
existing pre-hospital ‘code stroke’ systems, including systematic pre-notification of 
the receiving hospital, will have to be supported by RCTs.  In spite of recent 
studies reporting the feasibility of mobile emergency stroke units in delivering 
intravenous thrombolysis at the scene, there is currently no evidence that this 
costly intervention improves outcome. Mobile stroke units allowing CT angiography 
could be useful for the early identification of patients with large artery occlusion.  
We found no evidence for the pre-hospital use of laboratory biomarkers in 
diagnosing stroke, POC laboratory analysis for blood count and INR, and 
neuroprotective therapies. 
  
17 
 
 
 
 
 
 
 
 
 
 
18 
 
Disclosure of conflicts of Interest 
GAF developed the FAST and ROSIER scales and was chief Investigator of 
the PILFAST study. JDK is involved in pre-hospital telemedicine studies.  
  
19 
 
References 
1  Emberson J, Lees KR, Lyden P, et al. Effect of treatment delay, age, and 
stroke severity on the effects of intravenous thrombolysis with alteplase for acute 
ischaemic stroke: a meta-analysis of individual patient data from randomised 
trials. Lancet. 2014; 384: 1929-1935. 
2  Campbell BC, Donnan GA, Lees KR, et al. Endovascular stent thrombectomy: 
the new standard of care for large vessel ischaemic stroke. Lancet Neurol. 2015; 
14: 846-854. 
3  Leone MA, Brainin M, Boon P, et al. Guidance for the preparation of 
neurological management guidelines by EFNS scientific task forces - revised 
recommendations 2012. Eur J Neurol. 2013; 20: 410-419. 
4  Leone MA, Keindl M, Schapira AH, Deuschl G, Federico A. Practical 
recommendations for the process of proposing, planning and writing a 
neurological management guideline by EAN task forces. Eur J Neurol. 2015; 22: 
1505-1510. 
5  Ntaios G, Bornstein NM, Caso V, et al. The European Stroke Organisation 
Guidelines: a standard operating procedure. Int J Stroke. 2015; 10 Suppl A100: 128-
135. 
6  Brandler ES, Sharma M, Sinert RH, Levine SR. Prehospital stroke scales in 
urban environments: a systematic review. Neurology. 2014; 82: 2241-2249. 
7  Nazliel B, Starkman S, Liebeskind DS, et al. A brief prehospital stroke 
severity scale identifies ischemic stroke patients harboring persisting large 
arterial occlusions. Stroke. 2008; 39: 2264-2267. 
8  Perez de la Ossa N, Carrera D, Gorchs M, et al. Design and validation of a 
prehospital stroke scale to predict large arterial occlusion: the rapid arterial 
occlusion evaluation scale. Stroke. 2014; 45: 87-91. 
9  Pountain SJ, Roffe C. Does routine oxygen supplementation in patients with 
acute stroke improve outcome? BMJ. 2012; 345: e6976. 
10  Ali K, Warusevitane A, Lally F, et al. The stroke oxygen pilot study: a 
randomized controlled trial of the effects of routine oxygen supplementation early 
after acute stroke--effect on key outcomes at six months. PLoS One. 2014; 8: 
e59274. 
20 
 
11  Roffe C, Ali K, Warusevitane A, et al. The SOS pilot study: a RCT of routine 
oxygen supplementation early after acute stroke--effect on recovery of 
neurological function at one week. PLoS One. 2011; 6: e19113. 
12  Rowat AM, Dennis MS, Wardlaw JM. Hypoxaemia in acute stroke is frequent 
and worsens outcome. Cerebrovasc Dis. 2006; 21: 166-172. 
13  Bosson N, Gausche-Hill M, Koenig W. Implementation of a titrated oxygen 
protocol in the out-of-hospital setting. Prehosp Disaster Med. 2014; 29: 403-408. 
14  Castillo J, Leira R, Garcia MM, Serena J, Blanco M, Davalos A. Blood pressure 
decrease during the acute phase of ischemic stroke is associated with brain injury 
and poor stroke outcome. Stroke. 2004; 35: 520-526. 
15  Ankolekar S, Fuller M, Cross I, et al. Feasibility of an ambulance-based 
stroke trial, and safety of glyceryl trinitrate in ultra-acute stroke: the rapid 
intervention with glyceryl trinitrate in Hypertensive Stroke Trial (RIGHT, 
ISRCTN66434824). Stroke. 2013; 44: 3120-3128. 
16  Shaw L, Price C, McLure S, et al. Paramedic Initiated Lisinopril For Acute 
Stroke Treatment (PIL-FAST): results from the pilot randomised controlled trial. 
Emerg Med J. 2014; 31: 994-999. 
17  Jauch EC, Saver JL, Adams HP, Jr., et al. Guidelines for the early management 
of patients with acute ischemic stroke: a guideline for healthcare professionals 
from the American Heart Association/American Stroke Association. Stroke. 2013; 
44: 870-947. 
18  Fang Y, Zhang S, Wu B, Liu M. Hyperglycaemia in acute lacunar stroke: a 
Chinese hospital-based study. Diab Vasc Dis Res. 2013; 10: 216-221. 
19  Uyttenboogaart M, Koch MW, Stewart RE, Vroomen PC, Luijckx GJ, De Keyser 
J. Moderate hyperglycaemia is associated with favourable outcome in acute 
lacunar stroke. Brain. 2007; 130: 1626-1630. 
20  Nurmi J, Lindsberg PJ, Happola O, Klemetti E, Westerbacka J, Castren M. 
Strict glucose control after acute stroke can be provided in the prehospital setting. 
Acad Emerg Med. 2011; 18: 436-439. 
21  Bellolio MF, Gilmore RM, Ganti L. Insulin for glycaemic control in acute 
ischaemic stroke. Cochrane Database Syst Rev. 2014; 1: CD005346. 
21 
 
22  Saini M, Saqqur M, Kamruzzaman A, Lees KR, Shuaib A, Investigators V. 
Effect of hyperthermia on prognosis after acute ischemic stroke. Stroke. 2009; 40: 
3051-3059. 
23  Boysen G, Christensen H. Stroke severity determines body temperature in 
acute stroke. Stroke. 2001; 32: 413-417. 
24  Berglund A, Svensson L, Sjostrand C, et al. Higher prehospital priority level 
of stroke improves thrombolysis frequency and time to stroke unit: the Hyper 
Acute STroke Alarm (HASTA) study. Stroke. 2012; 43: 2666-2670. 
25  Abdullah AR, Smith EE, Biddinger PD, Kalenderian D, Schwamm LH. Advance 
hospital notification by EMS in acute stroke is associated with shorter door-to-
computed tomography time and increased likelihood of administration of tissue-
plasminogen activator. Prehosp Emerg Care. 2008; 12: 426-431. 
26  Belvis R, Cocho D, Marti-Fabregas J, et al. Benefits of a prehospital stroke 
code system. Feasibility and efficacy in the first year of clinical practice in 
Barcelona, Spain. Cerebrovasc Dis. 2005; 19: 96-101. 
27  Casolla B, Bodenant M, Girot M, et al. Intra-hospital delays in stroke patients 
treated with rt-PA: impact of preadmission notification. J Neurol. 2013; 260: 635-
639. 
28  Quain DA, Parsons MW, Loudfoot AR, et al. Improving access to acute stroke 
therapies: a controlled trial of organised pre-hospital and emergency care. Med J 
Aust. 2008; 189: 429-433. 
29  Kim SK, Lee SY, Bae HJ, et al. Pre-hospital notification reduced the door-to-
needle time for iv t-PA in acute ischaemic stroke. Eur J Neurol. 2009; 16: 1331-1335. 
30  Gladstone DJ, Rodan LH, Sahlas DJ, et al. A citywide prehospital protocol 
increases access to stroke thrombolysis in Toronto. Stroke. 2009; 40: 3841-3844. 
31  O'Brien W, Crimmins D, Donaldson W, et al. FASTER (Face, Arm, Speech, 
Time, Emergency Response): experience of Central Coast Stroke Services 
implementation of a pre-hospital notification system for expedient management 
of acute stroke. J Clin Neurosci. 2012; 19: 241-245. 
32  Meretoja A, Strbian D, Mustanoja S, Tatlisumak T, Lindsberg PJ, Kaste M. 
Reducing in-hospital delay to 20 minutes in stroke thrombolysis. Neurology. 2012; 
79: 306-313. 
22 
 
33  Bergrath S, Reich A, Rossaint R, et al. Feasibility of prehospital 
teleconsultation in acute stroke--a pilot study in clinical routine. PLoS One. 2012; 
7: e36796. 
34  Yperzeele L, Van Hooff RJ, De Smedt A, et al. Feasibility of AmbulanCe-
Based Telemedicine (FACT) Study: Safety, Feasibility and Reliability of Third 
Generation In-Ambulance Telemedicine. PLoS One. 2014; 9: e110043. 
35  Walter S, Kostopoulos P, Haass A, et al. Diagnosis and treatment of patients 
with stroke in a mobile stroke unit versus in hospital: a randomised controlled 
trial. Lancet Neurol. 2012; 11: 397-404. 
36  Ebinger M, Winter B, Wendt M, et al. Effect of the use of ambulance-based 
thrombolysis on time to thrombolysis in acute ischemic stroke: a randomized 
clinical trial. JAMA. 2014; 311: 1622-1631. 
37  Weber JE, Ebinger M, Rozanski M, et al. Prehospital thrombolysis in acute 
stroke: results of the PHANTOM-S pilot study. Neurology. 2013; 80: 163-168. 
38  Dietrich M, Walter S, Ragoschke-Schumm A, et al. Is prehospital treatment 
of acute stroke too expensive? An economic evaluation based on the first trial. 
Cerebrovasc Dis. 2014; 38: 457-463. 
39  Gyrd-Hansen D, Olsen KR, Bollweg K, Kronborg C, Ebinger M, Audebert HJ. 
Cost-effectiveness estimate of prehospital thrombolysis: results of the PHANTOM-
S study. Neurology. 2015; 84: 1090-1097. 
40  Rizos T, Herweh C, Jenetzky E, et al. Point-of-care international normalized 
ratio testing accelerates thrombolysis in patients with acute ischemic stroke using 
oral anticoagulants. Stroke. 2009; 40: 3547-3551. 
41  Walter S, Kostopoulos P, Haass A, et al. Point-of-care laboratory halves door-
to-therapy-decision time in acute stroke. Ann Neurol. 2011; 69: 581-586. 
42  Hasan N, McColgan P, Bentley P, Edwards RJ, Sharma P. Towards the 
identification of blood biomarkers for acute stroke in humans: a comprehensive 
systematic review. Br J Clin Pharmacol. 2012; 74: 230-240. 
43  Reiner-Deitemyer V, Teuschl Y, Matz K, et al. Helicopter transport of stroke 
patients and its influence on thrombolysis rates: data from the Austrian Stroke 
Unit Registry. Stroke. 2011; 42: 1295-1300. 
23 
 
44  Horn J, de Haan RJ, Vermeulen M, Limburg M. Very Early Nimodipine Use in 
Stroke (VENUS): a randomized, double-blind, placebo-controlled trial. Stroke. 2001; 
32: 461-465. 
45  Saver JL, Starkman S, Eckstein M, et al. Prehospital use of magnesium 
sulfate as neuroprotection in acute stroke. N Engl J Med. 2015; 372: 528-536. 
46  Hougaard KD, Hjort N, Zeidler D, et al. Remote ischemic perconditioning as 
an adjunct therapy to thrombolysis in patients with acute ischemic stroke: a 
randomized trial. Stroke. 2014; 45: 159-167. 
 
